GT Biopharma, Inc. reports

Company location: San Francisco, CA
Fiscal year end: 31 December

GT Biopharma, Inc. has filed 868 SEC EDGAR filings since 12 May 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 509 matching filings.

Per page

Current page

PRIMARY DOCUMENT

Filing date: 01 Dec 2017
Reporting date: 01 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 01 Dec 2017
Reporting date: 01 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

PRIMARY DOCUMENT

Filing date: 16 Nov 2017
Reporting date: 16 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 14 Nov 2017
Reporting date: 30 Sep 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-32837

THEOREM GROUP LLC 13G FOR GT BIOPHARMA, INC.

Filing date: 14 Nov 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

CURRENT REPORT

Filing date: 12 Oct 2017
Reporting date: 10 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-32837

AMENDMENT NO. 9

Filing date: 10 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-32837

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date: 20 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

D File 021-294767

D filing

Filing date: 14 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

CURRENT REPORT

Filing date: 05 Sep 2017
Reporting date: 01 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 11 Aug 2017
Reporting date: 30 Jun 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-08092

GT BIOPHARMA 8-K

Filing date: 25 Jul 2017
Reporting date: 17 Jul 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

RW File 333-213270

OXIS WITHDRAWAL OF REGISTRATION STATEMENT

Filing date: 24 Jul 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

PRIMARY DOCUMENT

Filing date: 26 Jun 2017
Reporting date: 26 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14C File 000-08092

OXIS DEF 14C

Filing date: 12 May 2017
Reporting date: 12 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 09 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRER14C File 000-08092

OXIS PRE14C REVISION 3

Filing date: 05 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-08092

QUARTERLY REPORT

Filing date: 28 Apr 2017
Reporting date: 31 Mar 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRER14C File 000-08092

OXIS PRE 14C REVISION 2

Filing date: 24 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 20 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRER14C File 000-08092

OXIS REVISED PRE 14C

Filing date: 14 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 06 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-08092

OXIS 8-K ITEM 8.01

Filing date: 03 Apr 2017
Reporting date: 03 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-08092

ANNUAL REPORT

Filing date: 31 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRE 14C File 000-08092

OXIS PRE 14C TO EFFECT REVERSE SPLIT AND INCREASE AUTHORIZED SHARES

Filing date: 24 Mar 2017
Reporting date: 24 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing